Clinical trials
Hyperphosphatemia trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Unknown status | 5 |
| Withdrawn | 2 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2 |
| University College Cork | 2 |
| Ajou University School of Medicine | 1 |
| Bo Feldt-Rasmussen | 1 |
| Brigham and Women's Hospital | 1 |
| Denver Nephrologists, P.C. | 1 |
| Endeavor Health | 1 |
| Faculdade de Ciências Médicas da Santa Casa de São Paulo | 1 |
| Federico II University | 1 |
| Fresenius Medical Care North America | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperphosphatemia | 28 |
| Kidney Failure, Chronic | 10 |
| Renal Insufficiency, Chronic | 6 |
| Cardiovascular Diseases | 2 |
| Atherosclerosis | 1 |
| Bone Diseases, Metabolic | 1 |
| Glucose Intolerance | 1 |
| Hyperkalemia | 1 |
| Hypoalbuminemia | 1 |
| Inflammation | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.